Patents

De Jersey J.,  Guddat L.W.,  Hocková D., Keough D.T.
New substituted fused heterocyclic compounds are hypoxanthine-guanine-(xanthine) phosphoribosyltransferase inhibitors useful to treat or prevent microbial infection caused by e.g. Plasmodium falciparum or Giardia lamblia
WO2013166545-A2 (2013).

Jansa P., Baszczyňski O., Holý A., Janeba Z.:
A method of the production of substituted phosphonic acid diamides
Czech Appl. PV 2011-26 (2011).

Jansa P., Holý A., Zídek Z., Kmoníčková E., Janeba Z.:
Pyrimidine compounds inhibiting nitric monoxide and prostaglandine E2, method of their production and usage
Czech Appl. PV 2011-103 (2011).

Jansa P., Baszczyňski O., Holý A.:
A method of total degradation of organophosphate and organophosphonate pesticides, herbicides, pollutants, nerve agents, and their precursors
Czech Appl. PV 2011-325 (2011).

Jansa P., Holý A., Česnek M.:
Method of synthesis of dialkyl haloalkylphosphonates and dialkyl haloalkoxyalkylphosphonates
Czech Appl. PV 2010-583 (2010).

Balzarini J., De Clercq E., Hocková D., Holý A.:
Pyrimidine compounds having phosphonate groups as antivirals nucleodite analogs.
WO/2004/111064; PCT/CZ2004/000034; US Patent 7,115,592 (2006); New Zealand Patent 543864 (2009).